CDT Equity Inc. (CDT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $407,550
Last updated: Nov 17, 2026 at 11:04 AM ET
CDT Equity Inc. (CDT) Financials: Revenue, Profit and Cash Flow
CDT Equity reported revenue of $2.72B for the fiscal year ended Dec 31, 2025, up 194.4% from the year before. That year, net income was -$39.22M with a net margin of -1.4%, operating cash flow was -$15.55M and free cash flow was -$17.96M. The quarter ended Jun 30, 2026 had revenue of $750.16M and net income of $68.54M.
Revenue and Margins
The operating margin was -1.4% in the fiscal year ended Dec 2025.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $2.72B | +194.4% | 38.0% | -1.4% | -1.4% |
| Dec 2024 | $922.22M | N/A | 0.0% | -1.7% | -1.9% |
| Dec 2023 | $0 | N/A | N/A | N/A | N/A |
| Dec 2022 | $0 | N/A | N/A | N/A | N/A |
| Dec 2021 | $0 | N/A | N/A | N/A | N/A |
Income Statement
In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Jun 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | $2.72B | $922.22M | $0 | $0 | $0 |
| Cost of revenue | $1.68B | $457.00K | N/A | N/A | N/A |
| Gross profit | $1.03B | -$457.00K | N/A | N/A | N/A |
| Research and development | $5.05M | $3.38M | $90.00K | $111.00K | $283.00K |
| Operating income | -$36.76M | -$15.42M | -$5.26M | -$3.16M | -$3.17M |
| Net income | -$39.22M | -$17.80M | -$535.00K | -$4.89M | -$3.66M |
| EBITDA | -$36.48M | N/A | $3.05M | N/A | N/A |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $750.16M | $696.38M | $2.72B | $698.22M | $671.99M | $624.86M | $1.08B | $654.93M | -$1.35B | $535.67M | $0 | $0 |
| Gross profit | $301.03M | $258.09M | -$515.00K | -$885.00K | -$828.00K | -$190.00K | -$452.00K | -$5.00K | -$695.87M | $201.60M | N/A | N/A |
| Operating income | $117.37M | $77.96M | -$21.16M | -$7.03M | -$4.95M | -$3.62M | -$3.51M | -$5.81M | -$3.14M | -$2.96M | -$895.00K | -$430.00K |
| Net income | $68.54M | $51.03M | -$21.32M | -$7.12M | -$6.03M | -$4.75M | -$2.41M | -$6.46M | -$5.38M | -$3.55M | $1.78M | $2.63M |
Balance Sheet
As of Dec 2025, cash and equivalents of $389.89M were 11.0% of total assets of $3.54B, against total liabilities of $2.28B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total assets | $3.54B | $4.19M | $7.22M | $5.00K | $213.13K |
| Current assets | $1.35B | $2.71M | $5.73M | $646.64K | $104.16K |
| Cash and equivalents | $389.89M | $554.00K | $4.23M | $345.78K | $48.55K |
| Total liabilities | $2.28B | $10.99M | $7.68M | $10.09M | $192.51K |
| Short-term debt | N/A | $7.35M | $985.00K | $175.00K | $177.06K |
| Long-term debt | N/A | N/A | N/A | $2.01M | $749.00K |
| Shareholder equity | $1.26B | -$6.79M | -$457.00K | -$10.09M | $20.62K |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.50B | $3.46B | $3.54B | $8.55M | $7.99M | $7.32M | $4.19M | $2.99M | $3.31M | $4.92M | $7.22M | $12.02M |
| Total liabilities | $2.12B | $2.18B | $2.28B | $4.27M | $4.46M | $4.63M | $10.99M | $12.11M | $8.77M | $8.02M | $7.68M | $13.10M |
| Cash and equivalents | $348.65M | $272.15M | $389.89M | $3.84M | $3.33M | $2.13M | $554.00K | $71.00K | $219.00K | $1.84M | $4.23M | $8.64M |
| Shareholder equity | $1.38B | $1.28B | $1.26B | $4.28M | $3.53M | $2.69M | -$6.79M | -$9.12M | -$5.46M | -$3.10M | -$457.00K | -$1.08M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$15.55M | -$9.68M | -$7.72M | -$2.27M | -$2.15M |
| Capital expenditures | $2.40M | $51.00K | $0 | $0 | $5 |
| Free cash flow | -$17.96M | -$9.73M | -$7.72M | -$2.27M | -$2.15M |
| Dividends paid | $7.97M | $8.20M | N/A | N/A | N/A |
| Investing cash flow | -$808.00K | -$43.00K | $725.00K | -$183.00K | $48.55K |
| Financing cash flow | $17.42M | $6.07M | $10.93M | $2.45M | $1.90M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $42.74M | -$18.67M | -$4.64M | $105.01M | -$2.58M | $7.44M | -$3.81M | -$2.00M | -$1.51M | -$2.36M | -$4.80M | -$524.00K |
| Capital expenditures | $40.66M | $44.39M | $1.00M | $39.68M | $1.00K | $32.20M | $80.33M | $41.00K | $10.00K | $24.25M | $0 | $0 |
| Free cash flow | $2.08M | -$63.06M | -$5.64M | $65.33M | -$2.58M | -$24.76M | -$84.14M | -$2.04M | -$1.52M | -$26.61M | -$4.80M | -$524.00K |
Frequently Asked Questions About CDT
What is CDT Equity's annual revenue?
CDT Equity reported revenue of $2.72B for the fiscal year ended Dec 31, 2025.
How fast is CDT Equity's revenue growing?
Revenue was up 194.4% for the fiscal year ended Dec 31, 2025 compared with the year before.
Is CDT Equity profitable?
No. CDT Equity reported net income of -$39.22M for the fiscal year ended Dec 31, 2025, with a net margin of -1.4%.
How much free cash flow does CDT generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$15.55M minus capital expenditures of $2.40M produced free cash flow of -$17.96M.
How much debt does CDT Equity have?
The balance sheet dated Dec 31, 2025 reported cash and equivalents of $389.89M.
CDT pages: Overview, Financials, Competitors